Tirzepatide - 17mg
This vial provides a 4-week supply of 17mg tirzepatide, totaling 68mg per vial.
- This is a supra-therapeutic dose.
- Requires provider approval and medical supervision.
- Not FDA approved.
Variants (1)
- Default Title — 499.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
66%